Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael F Walsh

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
JCO Precision Oncology|March 12, 2019
Genomic Characterization of Upper-Tract Urothelial Carcinoma in Patients With Lynch SyndromeTimothy F Donahue, Aditya Bagrodia, François Audenet, et al.
Human Mutation|August 25, 2019
Fumarate hydratase FH c.1431_1433dupAAA (p.Lys477dup) variant is not associated with cancer including renal cell carcinomaLiying Zhang, Michael F Walsh, Sowmya Jairam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2024
Update on Recommendations for Surveillance for Children with Predisposition to Hematopoietic MalignancyLuke D Maese, Marcin W Wlodarski, Sun Young Kim, et al.
Neuro-Oncology|November 19, 2024
Phase 2 trial of veliparib, local irradiation, and temozolomide in patients with newly diagnosed high-grade glioma: a Children's Oncology Group studyMatthias A Karajannis, Arzu Onar-Thomas, Tong Lin, et al.
Ophthalmology|May 19, 2020
Recommendations for Long-Term Follow-up of Adults with Heritable RetinoblastomaEmily S Tonorezos, Danielle Novetsky Friedman, Dana Barnea, et al.
Cancer Discovery|July 29, 2022
Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic TransformationSisi Chen, Rahul S Vedula, Antonio Cuevas-Navarro, et al.
Nature Communications|February 13, 2021
The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasmsJason R Schwartz, Jing Ma, Jennifer Kamens, et al.
Cancer|August 30, 2022
Disparities in cancer genetics care by race/ethnicity among pan-cancer patients with pathogenic germline variantsYing L Liu, Anna Maio, Yelena Kemel, et al.
European Urology Oncology|October 16, 2021
Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic TestingHong Truong, Rania Sheikh, Ritesh Kotecha, et al.
HGG Advances|October 5, 2023
Multiple TP53 p.R337H haplotypes and implications for tumor susceptibilityEmilia M Pinto, Cintia Fridman, Bonald C Figueiredo, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
JCO Precision Oncology|March 12, 2019
Genomic Characterization of Upper-Tract Urothelial Carcinoma in Patients With Lynch SyndromeTimothy F Donahue, Aditya Bagrodia, François Audenet, et al.
Human Mutation|August 25, 2019
Fumarate hydratase FH c.1431_1433dupAAA (p.Lys477dup) variant is not associated with cancer including renal cell carcinomaLiying Zhang, Michael F Walsh, Sowmya Jairam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2024
Update on Recommendations for Surveillance for Children with Predisposition to Hematopoietic MalignancyLuke D Maese, Marcin W Wlodarski, Sun Young Kim, et al.
Neuro-Oncology|November 19, 2024
Phase 2 trial of veliparib, local irradiation, and temozolomide in patients with newly diagnosed high-grade glioma: a Children's Oncology Group studyMatthias A Karajannis, Arzu Onar-Thomas, Tong Lin, et al.
Ophthalmology|May 19, 2020
Recommendations for Long-Term Follow-up of Adults with Heritable RetinoblastomaEmily S Tonorezos, Danielle Novetsky Friedman, Dana Barnea, et al.
Cancer Discovery|July 29, 2022
Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic TransformationSisi Chen, Rahul S Vedula, Antonio Cuevas-Navarro, et al.
Nature Communications|February 13, 2021
The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasmsJason R Schwartz, Jing Ma, Jennifer Kamens, et al.
Cancer|August 30, 2022
Disparities in cancer genetics care by race/ethnicity among pan-cancer patients with pathogenic germline variantsYing L Liu, Anna Maio, Yelena Kemel, et al.
European Urology Oncology|October 16, 2021
Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic TestingHong Truong, Rania Sheikh, Ritesh Kotecha, et al.
HGG Advances|October 5, 2023
Multiple TP53 p.R337H haplotypes and implications for tumor susceptibilityEmilia M Pinto, Cintia Fridman, Bonald C Figueiredo, et al.
Pageof 9